Higher remnant cholesterol is associated with an increased risk of amnestic mild cognitive impairment: a

Yating Ai1,2,3, Chunyi Zhou1, Ming Wang4

  • 1School of Nursing, Hubei University of Chinese Medicine, Wuhan, China.

PubMed
Abstract

Insights

Higher remnant cholesterol (RC) levels are linked to amnestic mild cognitive impairment (aMCI) in older adults. This study suggests RC may be an independent indicator for aMCI, especially affecting naming abilities.

Area of Science:

  • Neuroscience
  • Cardiovascular Research
  • Gerontology

Background:

  • Amnestic mild cognitive impairment (aMCI) is a common precursor to Alzheimer's disease.
  • Remnant cholesterol (RC) is an emerging, overlooked risk factor for cognitive decline.

Purpose of the Study:

  • To investigate the association between plasma remnant cholesterol (RC) levels and amnestic mild cognitive impairment (aMCI).

Main Methods:

  • A total of 1,007 community-dwelling elders were recruited and categorized into aMCI (n=401) and normal cognitive groups (n=606).
  • Data collected included demographic information, cognitive screening, physical examinations, and blood lipid profiles.
  • Statistical analyses included binary logistic regression, partial correlation, and ROC curve analysis.

Main Results:

  • Individuals with aMCI exhibited significantly higher plasma RC levels compared to the normal cognitive group (p < 0.05).
  • RC levels were identified as an independent associated factor for aMCI (OR=1.477, p=0.014).
  • Higher RC levels correlated negatively with MoCA and Naming scores, and demonstrated independent predictive efficacy for aMCI (AUC=0.580, p < 0.001).

Conclusions:

  • Elevated plasma RC levels are an independent indicator for aMCI in older adults.
  • The association appears particularly relevant to the naming cognitive domain.
  • Further longitudinal research is warranted to confirm the predictive value of RC for aMCI.

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35